In The Fight

in the fight

In The Fight

At SOPHiA GENETICS, we combine expertise in science and tech to support the scientific community with data-driven medicine solutions.

Since inception, we have used this expertise to build a unique, accurate and universal platform for a more sustainable global healthcare system.
That’s why, when the COVID pandemic began, we decided to leverage on our technology to help turn the tide.

Today, we are very proud to say we are IN THE FIGHT.

Through leadership – and in-line with WHO guidance – we have developed and published guidelines for the accurate genotyping of SARS-CoV-2.

Through collaboration with our partners, we have developed a new end-to-end approach that will enable the scientific community to identify new variants of SARS-CoV-2 as and when they arise.

And with a focus on valuable insights, we are able to give healthcare professionals, scientists, and governments the answers they need to fight SARS-CoV-2 so that together we can turn the tide.

SOPHiA GENETICS – In the Fight

Paragon Genomics SARS-CoV-2 Panels powered by SOPHiA DDM™ platform can better support your research needs by identifying new and emerging strains


book icon


We’re very proud to have developed and published guidelines – in-line with WHO guidance – for the accurate genotyping of SARS-CoV-2.
mountain icon


One of our Genomic Research Experts, Dr. Slawomir Kubik, shared his belief in the ability of data-driven approaches to help in the fight against COVID-19.
mountain icon

APHL 2021

Our Genomic Research Expert, Slawomir, presented a new case study of W152 mutations and why they are concerning at APHL 2021.


collaborate icon

Joined Forces

SOPHiA GENETICS and Paragon Genomics join forces against the COVID-19 coronavirus pandemic.
magnifying glass


Webinar: Turn your Sequencing Lab into a COVID-19 Research and Surveillance Powerhouse.


webinar icon

PMWC 2021

Our co-founder Lars Steinmetz joined an expert panel at PMWC 2021, to discuss the opportunities in ‘Tracking COVID-19 with a System Clinical Approach’.
chat icon

SARS-CoV-2: How to make the most out of your samples

In this discussion, our expert will share insights on the different approaches to monitor viral genome sequences and how your data can help fuel surveillance efforts.
insights icon

Discover SOPHiA DDM™

SOPHiA DDM™ is an intuitive platform that enables the rapid identification of new variants and catalyzes knowledge sharing in a secure peer network. Contact us for a demo.
pink dots icon

Find out how SOPHiA GENETICS can support your specific research and surveillance needs.

Paragon Genomics SARS-CoV-2 Panels powered by SOPHiA DDM™ platform offer full SARS-CoV-2 genome analyses and identifies new and emerging strains* including:
‘UK’ (B.1.1.7)
‘South African’ (B.1.351)
‘Brazilian’ (P.1)
‘Southern Californian’ (B.1.429)
‘Indian’ (B.1.167.2)